Published in Immunogenetics on March 29, 2006
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One (2010) 1.62
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J Immunol (2013) 1.05
HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol (2010) 0.98
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics (2013) 0.98
The Mhc class II of the Black grouse (Tetrao tetrix) consists of low numbers of B and Y genes with variable diversity and expression. Immunogenetics (2007) 0.94
Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E. BMC Genet (2007) 0.91
Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma. Immunogenetics (2011) 0.83
Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide. Immunogenetics (2010) 0.78
Characterisation of major histocompatibility complex class I genes at the fetal-maternal interface of marsupials. Immunogenetics (2015) 0.76
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone Marrow Res (2014) 0.75
Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16
Consed: a graphical tool for sequence finishing. Genome Res (1998) 59.36
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered (2003) 14.37
Complete MHC haplotype sequencing for common disease gene mapping. Genome Res (2004) 12.09
Gene map of the extended human MHC. Nat Rev Genet (2004) 6.01
A class I antigen, HLA-G, expressed in human trophoblasts. Science (1990) 4.36
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A (1998) 3.35
A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A (1987) 2.77
HLA-G and immune tolerance in pregnancy. FASEB J (2005) 2.37
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A (2003) 2.33
Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res (2004) 2.32
HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol (1998) 2.09
Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet (2004) 2.03
Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A (1992) 1.95
HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol (1988) 1.73
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity (1995) 1.63
HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol (1998) 1.60
Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol (2003) 1.60
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol (1994) 1.53
The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus. J Hematother Stem Cell Res (2003) 1.38
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem (2002) 1.38
Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med (1990) 1.33
Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol (2005) 1.27
Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet (2003) 1.27
The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments. J Immunol (1992) 1.25
Genetics of the immune response: identifying immune variation within the MHC and throughout the genome. Immunol Rev (2002) 1.21
Detecting highly conserved regions of the human genome by multispecies sequence comparisons. Cold Spring Harb Symp Quant Biol (2003) 1.20
Reconstructing the genomic architecture of mammalian ancestors using multispecies comparative maps. Hum Genomics (2003) 1.17
The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol Hum Reprod (2001) 1.03
Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod (2004) 1.03
Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol (2000) 0.99
The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol (1998) 0.99
Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism. Hum Immunol (1992) 0.99
HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol (2003) 0.97
Structure of the HLA class I region and expression of its resident genes. Curr Opin Immunol (1993) 0.95
HLA-G unique promoter region: functional implications. Immunogenetics (2001) 0.94
Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens (2004) 0.92
Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data. Tissue Antigens (2002) 0.90
Re-examination of HLA-G polymorphism in African Americans. Immunogenetics (1999) 0.88
How useful is the fine-scale mapping of complex trait linkage peaks? Evaluating the impact of additional microsatellite genotyping on the posterior probability of linkage. Genet Epidemiol (2005) 0.86
HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens (2004) 0.85
Data acquisition, data storage, and data presentation in a modern genetics laboratory. Rev Immunogenet (2000) 0.83
HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol (2004) 0.83
In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner. Immunology (2004) 0.83
Polymorphism of HLA-G gene and protein. J Reprod Immunol (1999) 0.79
Placental expression of HLA class I genes. Am J Reprod Immunol (1996) 0.79
Linkage disequilibrium grouping of single nucleotide polymorphisms (SNPs) reflecting haplotype phylogeny for efficient selection of tag SNPs. Genetics (2005) 0.78
Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity (2005) 23.00
A fine-scale linkage-disequilibrium measure based on length of haplotype sharing. Am J Hum Genet (2006) 6.02
Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature (2009) 5.96
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med (2008) 4.16
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med (2003) 3.30
A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. Am J Hum Genet (2003) 2.88
Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res (2004) 2.32
Gene expression analyzed by high-resolution state array analysis and quantitative proteomics: response of yeast to mating pheromone. Mol Cell Proteomics (2004) 2.22
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev (2002) 2.21
Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 2.08
Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03
Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics (2003) 1.91
Evaluation of published single nucleotide polymorphisms associated with acute GVHD. Blood (2012) 1.88
Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One (2010) 1.62
Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J Virol (2006) 1.62
Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.60
Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol (2003) 1.60
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
The transcriptome and its translation during recovery from cell cycle arrest in Saccharomyces cerevisiae. Mol Cell Proteomics (2003) 1.45
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell (2011) 1.44
A regression-based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington's disease transgenic model. Hum Mol Genet (2002) 1.43
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet (2009) 1.40
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci U S A (2005) 1.39
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol (2010) 1.39
A new Late Miocene great ape from Kenya and its implications for the origins of African great apes and humans. Proc Natl Acad Sci U S A (2007) 1.38
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem (2002) 1.38
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood (2010) 1.38
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis (2008) 1.34
Accurate, precise modeling of cell proliferation kinetics from time-lapse imaging and automated image analysis of agar yeast culture arrays. BMC Syst Biol (2007) 1.33
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis (2006) 1.31
Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics (2006) 1.28
Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch Otolaryngol Head Neck Surg (2009) 1.27
Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol (2005) 1.27
Analysis of HLA-E expression in human tumors. Immunogenetics (2003) 1.23
Transcriptional expression profiles of oral squamous cell carcinomas. Cancer (2002) 1.23
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood (2012) 1.22
Genetics of the immune response: identifying immune variation within the MHC and throughout the genome. Immunol Rev (2002) 1.21
Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial. J Infect Dis (2011) 1.20
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. J Clin Invest (2014) 1.18
A class of models for analyzing GeneChip gene expression analysis array data. BMC Genomics (2005) 1.18
High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles. Immunogenetics (2007) 1.17
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics (2003) 1.16
Nomenclature for Factors of the HLA System, 2004. Hum Immunol (2005) 1.14
Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Mol Cancer (2010) 1.09
Single-stranded linear amplification protocol results in reproducible and reliable microarray data from nanogram amounts of starting RNA. Genomics (2004) 1.07
Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk. Cancer (2007) 1.07
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors. J Immunol (2013) 1.05
Soluble HLA-G isoforms: technical deficiencies lead to misinterpretations. Mol Hum Reprod (2005) 1.05
Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. J Infect Dis (2013) 1.04
HLA-F is a surface marker on activated lymphocytes. Eur J Immunol (2010) 1.03
Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Clin Immunol (2008) 1.02
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One (2009) 1.00
Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol (2008) 1.00
Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol (2003) 1.00
A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res (2009) 1.00
A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data. Theor Biol Med Model (2006) 0.98
HLA-F complex without peptide binds to MHC class I protein in the open conformer form. J Immunol (2010) 0.98
Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics (2013) 0.98
Predicting multiallelic genes using unphased and flanking single nucleotide polymorphisms. Genet Epidemiol (2010) 0.97
HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol (2003) 0.97
Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation. Curr Opin Hematol (2010) 0.96
Array rank order regression analysis for the detection of gene copy-number changes in human cancer. Genomics (2003) 0.95
Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma. Anticancer Res (2010) 0.94
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol (2013) 0.92
A soluble isoform of the rhesus monkey nonclassical MHC class I molecule Mamu-AG is expressed in the placenta and the testis. J Immunol (2002) 0.91
Can a metastatic gene expression profile outperform tumor size as a predictor of occult lymph node metastasis in oral cancer patients? Clin Cancer Res (2011) 0.90
The involvement of HLA-E and -F in pregnancy. J Reprod Immunol (2006) 0.90
Nomenclature for factors of the HLA system, 2002. Hum Immunol (2002) 0.88
Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chem Res Toxicol (2005) 0.87
The surface expression of HLA-F on decidual trophoblasts increases from mid to term gestation. J Reprod Immunol (2006) 0.87
Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum Immunol (2005) 0.86
Microarray comparative genomic hybridization reveals genome-wide patterns of DNA gains and losses in post-Chernobyl thyroid cancer. Radiat Res (2006) 0.86
Empirical evaluations of analytical issues arising from predicting HLA alleles using multiple SNPs. BMC Genet (2011) 0.85
Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am J Obstet Gynecol (2007) 0.85
Estimating Regression Parameters in an Extended Proportional Odds Model. J Am Stat Assoc (2012) 0.85
Polymorphisms in nucleotide excision repair genes and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2011) 0.85
Integrative genomics in combination with RNA interference identifies prognostic and functionally relevant gene targets for oral squamous cell carcinoma. PLoS Genet (2013) 0.84
A systematic search for SNPs/haplotypes associated with disease phenotypes using a haplotype-based stepwise procedure. BMC Genet (2008) 0.84
Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Am J Reprod Immunol (2009) 0.83
Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays. Mutat Res (2005) 0.82
An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients. J Oral Pathol Med (2007) 0.82
Complete hydatidiform mole in a triplet pregnancy coexisting two viable fetuses: case report and review of the literature. J Obstet Gynaecol Res (2003) 0.81
Integrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes. Otolaryngol Head Neck Surg (2012) 0.81
Prediction model for the incidence of emergent cesarean section during induction of labor specialized in nulliparous low-risk women. J Obstet Gynaecol Res (2011) 0.81
Nomenclature for factors of the HLA system, 2002. Eur J Immunogenet (2002) 0.81